Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This phase II trial studies how well hypofractionated proton or photon radiation therapy works in treating patients with brain tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells. A shorter duration of radiation treatment may avoid some of the delayed side effects of radiation while providing a more convenient treatment and reducing costs.
Epistemonikos ID: 052ae9dc6c061a576c5a02c7c7430fddd7ef030c
First added on: May 07, 2024